Author

A. Pinter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 4 Assay:proteomics· 4 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:dimensionality reduction· 1

Frequent Co-Authors

D. S. Boyle· 2 shared E. Moreau· 2 shared J. L. Cantera· 2 shared M. Kawasaki· 2 shared P. K. Drain· 2 shared W. Honnen· 2 shared A. Andama· 1 shared A. Choudhary· 1 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. S. Boyle

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Broad-Spectrum Heavily Mutated Monoclonal Antibody Isolated from COVID-19 Convalescent Vaccinee with Capacity to Neutralize SARS-CoV2 Variants Ranging from B.1 to BQ.1.1

A. K. Choudhary, D. Calianese, W. Honnen, A. Kolloli, R. J. Dikdan, D. Jaijyan, G. Song, T. Capozzola, V. Akkaraju, A. Mattappallil, A. Rosania, S. Khan, M. Lerman, N. Afzal, S. Subbian, , A. Pinter

The paper isolates and characterizes Acovimab, a broadly neutralizing monoclonal antibody against SARS-CoV-2 variants, showing potent neutralization against most variants except XBB.1.5 and synergistic activity with Sotrovimab.

bioRxiv · May 4, 2023 · PreprintImmunology

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

J. L. Cantera, L. M. Lillis, R. B. Peck, E. Moreau, J. A. Schouten, P. Davis, P. K. Drain, A. Andama, A. Pinter, M. Kawasaki, G. Kallenius, C. Sundling, K. M. Dobos, D. Flores, D. Chatterjee, , D. S. Boyle

This study evaluates new LAM-specific antibodies for TB diagnosis, finding that while some show strong binding to cultured LAM, their performance with urinary LAM varies, and no new antibodies outperform existing ones in clinical samples.

bioRxiv · Apr 12, 2022Microbiology

CAR-NK Cells Effectively Target the D614 and G614 SARS-CoV-2-infected Cells

M. Ma, S. Badeti, C.-H. Chen, A. Pinter, Q. Jiang, L. Shi, R. Zhou, H. Xu, Q. Li, W. Gause, D. Liu

This study demonstrates that S309-CAR-NK cells effectively target and kill SARS-CoV-2-infected cells, including the D614G mutant, outperforming CR3022-CAR-NK cells in vitro.

Frontiers in Immunology · Jul 23, 2021Peer-reviewedImmunology

Robust IgM responses following vaccination are associated with prevention of Mycobacterium tuberculosis infection in macaques

E. B. Irvine, A. O'Neil, P. A. Darrah, S. Shin, A. Choudhary, W. Li, W. Honnen, S. Mehra, D. Kaushal, H. P. Gideon, J. L. Flynn, M. Roederer, R. A. Seder, A. Pinter, S. Fortune, G. Alter

This study shows that IV BCG vaccination in macaques induces strong IgM responses associated with reduced Mtb bacterial burden and protection.

bioRxiv · May 6, 2021Immunology

Isolation and Purification of Lipoarabinomannan from Urine of Adults with Active Tuberculosis

J. L. Cantera, A. Rashid, L. Lillis, R. Peck, P. K. Drain, A. Pinter, M. Kawasaki, E. Moreau, D. S. Boyle

The paper isolates and purifies lipoarabinomannan from urine of adults with active tuberculosis to improve diagnostic sensitivity for TB.

bioRxiv · Mar 24, 2021 · PreprintMicrobiology